"Balancing Tech Gains with Health-Care Solutions: Cramer's Market Insights"

CNBC's Jim Cramer observed that while generative artificial intelligence has numerous applications in health care, Wall Street currently values its use more for targeted advertising, as evidenced by the stock gains of Amazon and Alphabet. He highlighted Nvidia's billion-dollar health-care business and praised pharma companies like Amgen and Roche for leveraging AI in drug discovery and development. Cramer noted that investors seem to prioritize computer science over vital health-care technology, emphasizing the current market focus on data analysis for advertising over life-saving innovations.